Both in Pharmaceuticals
Kura Oncology vs Zevra Therapeutics
Over the past year KURA returned −23.6% and ZVRA returned +14.1%; their daily moves had a correlation of 0.18.
KURA −23.6% ZVRA +14.1%Growth of $1, one year, split-adjusted
| Metric | KURA | ZVRA |
|---|---|---|
| Price | $7.61 | $11.17 |
| Market cap | $677.0M | $663.3M |
| Today | −22.98% | +8.87% |
| 1 month | −27.7% | +4.1% |
| 6 months | −20.4% | −0.7% |
| Year to date | −26.8% | +24.7% |
| 1 year | −22.1% | +9.4% |
| Revenue growth (YoY) | +36.5% | +44.9% |
| Gross margin | 98.8% | 95.2% |
| Net margin | −327.3% | 48.8% |
| P/E (TTM) | — | 8.6× |
| Price / sales | 8.8× | 4.5× |
| Net cash | $509.2M | $188.3M |
| Dividend yield | — | — |
| Volatility (60d) | 76.9% | 47.6% |
| Short % of float | 18.3% | 10.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).